April 27th, 2007
An enzyme that can be used to predict the survival and recurrence rates for nasopharyngeal cancer have been isolated by Mayo Clinic Cancer Center scientists and collaborating Chinese researchers.
SULF2, a recently identified heparin-degrading endosulfatase, appears to be significantly overexpressed in nasopharyngeal cancers, providing hope of the eventual ability to predict recurrence and subsequent prognosis after […]
By Gloria Gamat -- 1 comment
April 26th, 2007
I was going to come here today to tell you all about my new job, but I got some link love from a friend on AIM and was so moved, that I decided to talk about the upcoming Overlooked Film Festival.
I’ve been a movie buff for as long as I can remember, and when Siskel […]
By Robin Dunn Bryant -- 0 comments
April 26th, 2007
Researchers at the University of Pittsburgh School of Medicine have developed a dendritic cell-based therapeutic vaccine that can successfully halt the progression of pancreatic cancer in some patients three years after vaccination.
The vaccine is made up of a synthetic version of MUC1 (a tumor-associated protein that is expressed by pancreatic tumor cells) combined with the […]
By Gloria Gamat -- 0 comments
April 26th, 2007
Usually, cancer patients take several medications at the same time, not only for treatment of cancer but for management of side effects and other secondary illness induced by the cancer itself or the cancer drug prescribed to them.
Because of that, cancer patients are a higher risk of potential drug interactions that could cause them unnecessary […]
By Gloria Gamat -- 0 comments
April 25th, 2007
When all other treatment options for colorectal cancer have been exhausted to no significant effect, cetuximab is the effective treatment option.
Such were the suggestion confirmed by a research study recently presented at the 2007 Annual Meeting of the American Association for Cancer Research
According to Derek Jonker, M.D., assistant professor at the University of Ottawa and […]
By Gloria Gamat -- 2 comments
April 24th, 2007
Black raspberries could be the next treatment against sunburn and skin cancer.
Topical compound made of black raspberries has been found to significantly slow the growth of squamous cell carcinomas of the skin in mice exposed to ultraviolet B (UVB) radiation.
Ultraviolet B (UVB) radiation is the most dangerous light in the solar spectrum; it inflames the […]
By Gloria Gamat -- 0 comments
April 24th, 2007
Cruciferous vegetables like broccoli, watercress, cabbage and cauliflower are rich sources of chemicals that not only stop the growth of human prostate cancer cells in mice but could also cut off the formation of blood vessels that feed tumors.
Such were the findings of a research team from University of Pittsburgh Cancer Institute led by Shivendra […]
By Gloria Gamat -- 0 comments
April 24th, 2007
Last week I did a consultation with the radiation oncologist. Initially I thought it was the “mapping” appointment where they do all of the configurations before the radiation started. Instead we sat down with the doctor where he described the procedures and gave me an outline of how the treatments would go. […]
By Robin Dunn Bryant -- 0 comments
April 23rd, 2007
It’s a pretty odd feeling for me today as I prepare myself to go to work. No more mid-day naps, no more pennies for pay. I feel like my entire life has been on pause since the diagnosis and that the past year has been some sort of lingering dream.
For the first time I’m […]
By Robin Dunn Bryant -- 2 comments
April 21st, 2007
In populations with high rates of colorectal, prostate, and breast cancer, cancer risk can be moderately reduced with a daily dose of adult-strength aspirin (at least 325mg/day) if taken for at least five years.
Eric Jacobs, Ph.D., of the American Cancer Society, together with colleagues looked for associations between long-term daily aspirin use (at […]
By Gloria Gamat -- 0 comments
Recent Comments